Androderm?

Androderm is a transdermal system used for testosterone replacement therapy [1]. It is a patch applied to the skin that delivers testosterone continuously [1].

What is Androderm prescribed for?

Androderm is indicated for testosterone replacement and/or restoration in males with signs and symptoms of deficiency or absence of endogenous testosterone [1]. This condition is also known as hypogonadism [1].

How does Androderm work?

The Androderm patch contains testosterone that is absorbed through the skin into the bloodstream. It is designed to provide a steady release of the hormone, mimicking the body's natural production patterns [1]. The patch is typically applied nightly to ensure adequate testosterone levels are maintained throughout the day [1].

What are the potential side effects of Androderm?

Common side effects reported with Androderm include skin reactions at the application site, such as itching, redness, and blistering [1]. Other potential side effects can include an increased red blood cell count, prostate enlargement, and changes in libido [1]. It is important for patients to discuss any concerns about side effects with their healthcare provider [1].

How does Androderm compare to other testosterone treatments?

Androderm is a transdermal patch, offering a different delivery method compared to other testosterone therapies like injections, gels, or implants [1]. Transdermal patches provide continuous delivery, while injections may lead to fluctuating levels [1]. Gels also offer topical delivery, but may pose a risk of transference to others through skin contact [1]. The choice of therapy often depends on individual patient needs, lifestyle, and medical history [1].

When does the Androderm patent expire?

Information on specific patent expiry dates for Androderm is not readily available without a specialized search. DrugPatentWatch.com provides detailed patent information for various medications, which may include Androderm [2].

Who makes Androderm?

Androderm is manufactured by AbbVie Inc. [1].

Where can I find more information about Androderm patents and exclusivity?

For comprehensive details regarding Androderm's patent status, exclusivity periods, and potential for generic competition, DrugPatentWatch.com is a valuable resource [2].

Sources

1. AbbVie Inc. (n.d.). Androderm Prescribing Information.
2. DrugPatentWatch.com. (n.d.).